購物車
幫助
021-54845833/15800441009
|
Background: |
Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels formed by a pentameric arrangement of alpha and beta subunits to create distinct muscle and neuronal receptors. Neuronal receptors are found throughout the peripheral and central nervous system where they are involved in fast synaptic transmission. This gene encodes an alpha subunit that is widely expressed in the brain. The proposed structure for nAChR subunits is a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region. Mutations in this gene cause autosomal dominant nocturnal frontal lobe epilepsy type 4. Single nucleotide polymorphisms (SNPs) in this gene have been associated with nicotine dependence. |
|
Applications: |
ELISA, WB, IHC |
|
Name of antibody: |
CHRNA2 |
|
Immunogen: |
Synthetic peptide of human CHRNA2 |
|
Full name: |
cholinergic receptor, nicotinic, alpha 2 (neuronal) |
|
SwissProt: |
Q15822 |
|
ELISA Recommended dilution: |
2000-5000 |
|
IHC positive control: |
Human cervical cancer and Human brain |
|
IHC Recommend dilution: |
25-100 |
|
WB Predicted band size: |
60 kDa |
|
WB Positive control: |
A172 and A549 cells |
|
WB Recommended dilution: |
500-2000 |
